These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34579611)

  • 1.
    Li C; Xu Z; Liu S; Huang R; Duan W; Wei X
    Biofouling; 2021 Sep; 37(8):818-829. PubMed ID: 34579611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
    J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of farnesol against oral candidiasis in mice.
    Hisajima T; Maruyama N; Tanabe Y; Ishibashi H; Yamada T; Makimura K; Nishiyama Y; Funakoshi K; Oshima H; Abe S
    Microbiol Immunol; 2008 Jul; 52(7):327-33. PubMed ID: 18667031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jiang L; Zheng L; Sun KA; Zhou P; Xu R; Gu J; Wei X
    Biofouling; 2020 May; 36(5):537-548. PubMed ID: 32551919
    [No Abstract]   [Full Text] [Related]  

  • 6. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Fernandes Costa A; Evangelista Araujo D; Santos Cabral M; Teles Brito I; Borges de Menezes Leite L; Pereira M; Correa Amaral A
    Med Mycol; 2019 Jan; 57(1):52-62. PubMed ID: 29361177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by
    Shen T; Tian B; Liu W; Yang X; Sheng Q; Li M; Wang H; Wang X; Zhou H; Han Y; Ding C; Sai S
    Microbiol Spectr; 2024 Apr; 12(4):e0424723. PubMed ID: 38415658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
    Hayama K; Ishibashi H; Ishijima SA; Niimi K; Tansho S; Ono Y; Monk BC; Holmes AR; Harding DR; Cannon RD; Abe S
    FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Cordeiro RA; Teixeira CE; Brilhante RS; Castelo-Branco DS; Paiva MA; Giffoni Leite JJ; Lima DT; Monteiro AJ; Sidrim JJ; Rocha MF
    Med Mycol; 2013 Jan; 51(1):53-9. PubMed ID: 22712455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anti-Biofilm Efficacy of Caffeic Acid Phenethyl Ester (CAPE)
    de Barros PP; Rossoni RD; Garcia MT; Kaminski VL; Loures FV; Fuchs BB; Mylonakis E; Junqueira JC
    Front Cell Infect Microbiol; 2021; 11():700305. PubMed ID: 34408988
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole.
    Bezerra CF; de Alencar Júnior JG; de Lima Honorato R; Dos Santos ATL; Pereira da Silva JC; Gusmão da Silva T; Leal ALAB; Rocha JE; de Freitas TS; Tavares Vieira TA; Bezerra MCF; Sales DL; Kerntopf MR; de Araujo Delmondes G; Filho JMB; Peixoto LR; Pinheiro AP; Ribeiro-Filho J; Coutinho HDM; Morais-Braga MFB; Gonçalves da Silva T
    Chem Phys Lipids; 2020 Nov; 233():104987. PubMed ID: 33058818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
    Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
    J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis.
    Fang J; Huang B; Ding Z
    J Prosthet Dent; 2021 Feb; 125(2):257-265. PubMed ID: 32165010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis.
    Ninomiya K; Maruyama N; Inoue S; Ishibashi H; Takizawa T; Oshima H; Abe S
    Biol Pharm Bull; 2012; 35(6):861-5. PubMed ID: 22687476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
    Xia J; Qian F; Xu W; Zhang Z; Wei X
    Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
    Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
    J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of oligonol, a low-molecular polyphenol formulation derived from lychee fruits on murine oral candidiasis].
    Hayama K; Ishibashi H; Kitadate K; Yamazaki M; Abe S
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(3):137-42. PubMed ID: 20716852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.